Tuesday, Jan 26 2021 | Time 13:58 Hrs(IST)
image
  • Tractor march: Farmers reach Red Fort
  • Republic Day celebrated in Bengal amid tight security
  • TRACTOR RALLY: FARMERS REACH RED FORT
  • Palaniswami presents Anna medal for Gallantry and other awards at R-Day fete
  • Youngest Telangana state emerging as 'The Strongest State’ in country: Governor Dr Soundararajan
  • Delhi metro shuts several stations
  • Tractor rally: Farmers reach ITO
  • COVID-19 vaccination drive: Over 20 lakh healthcare workers receive jabs since Jan 16
  • Several firsts of 72nd Republic Day Parade
  • India celebrates its 72nd R-Day, showcases military might, cultural diversity
  • Farmers break police cordon, moving towards central Delhi
  • Farmers' protest: Violence at Tikri, Singhu border
  • Agriculture Loan Wavier to benefit 9 lakh farmers, loans to be wavied off by March 31: Guv
  • Military might showcased as India celebrates 72nd R-Day
  • Odisha Governor Prof Ganeshi Lal unfurled the National flag
Business Economy


IIL to set up new viral antigen manufacturing facility in Telangana with Rs 75 cr investment

IIL to set up new viral antigen manufacturing facility in Telangana with Rs 75 cr investment

Hyderabad, Nov 25 (UNI) Indian Immunological Ltd (IIL), the market leader in veterinary biologicals, on Wednesday announced the ground-breaking of a new viral antigen manufacturing facility in Phase III of Genome Valley, Karkapatla, Ranga Reddy District of Telangana.



With investment of INR 75 crores in the upcoming facility, ILL expected to increase its capacity to supply additional quantities of high-quality and safe vaccines.



The new facility will be specially designed as a multiproduct facility and to cater to the need for viral vaccines in the pipeline that includes Dengue, Zika and Varicella, Hyderabad-based veterinary biological company said in a release here.



Our new facility is spread across 2000 square meters and is very well equipped for world class GMP production of Biosafety level 2 and 3 vaccines (BSL-2 and BSL-3).



The company also plans to utilize the cutting-edge facility to manufacture COVID-19 vaccines post completion of its R&D with Griffith University, Australia.



The Company also inaugurated a new Sterile Filling Facility that was commissioned last year at an additional investment of INR 75 crores.

This facility will increase IIL’s capacity to supply lifesaving vaccines such as the Anti Rabies Vaccine (ARV) – Abhayrab™.



As a part of the expansion plan, IIL will add over 150 new positions, bringing its total staff strength close to 1,500.

The new facility will boost the production capacity by over 35 per cent and increase the supply capacity to key markets where rabies vaccine is critically needed.



IIL Managing Director Dr. K Anand Kumar, said as we mark as one of the major players on the pediatric and rabies vaccine, this expansion of our manufacturing facility is our commitment to securing a healthy and sustainable future. The total investment of over INR 150 crores in in the same direction of our vision to increase the production capacities to ensure a reliable and affordable supply of high-quality vaccines to larger communities.



“This facility has been specially designed to cater to the need for various viral vaccines and it will boost our manufacturing capacity by 35%. The new plant is expected to be ready for operation by October 2021,” said Dr. Prasanna Deshpande, Deputy Managing Director, IIL.



IIL has 4 manufacturing facilities at various locations – Karkapatla (Telangana) – Human Vaccines & Animal Health Formulations; Ooty (Tamil Nadu )– Anti Rabies production unit; Hyderabad ( Telangana) – Human Biologicals Unit (Gachibowli) and animal vaccines unit; Dargaville (New Zealand - New Bovine Serum.



IIL exports various Human and animal vaccines to over 50 countries and currently employs around 1,300 people.

UNI KNR ASN 1745

More News

Savills brings global flexi workspace platform Workthere to India

25 Jan 2021 | 10:04 PM

MUMBAI, India, Jan. 25, 2021 /PRNewswire/ -- International real estate advisor and property consultants Savills India today announced the launch of Workthere in India. Workthere is a brokerage-backed online listing platform (www.workthere.in), for flexible, co-working and managed office spaces, across geographies.

see more..

Panasonic Life Solutions to set up its new manufacturing facility in AP with Rs 600 cr investments

25 Jan 2021 | 8:40 PM

Hyderabad, Jan 25 (UNI) Panasonic Life Solutions India (PLSI), a wholly-owned subsidiary of Panasonic Corporation, on Monday announced the groundbreaking ceremony of its new manufacturing facility in Sri City (Chittoor district), Andhra Pradesh and will commence its operations of manufacturing the electrical appliances by April, 2022.

see more..

MRPL’s Vermicomposting unit inaugurated by Sunil Kumar, Joint Secretary Refineries-MOPNG)

25 Jan 2021 | 7:33 PM

Mangaluru, Jan 25 (UNI) Sunil Kumar, Joint Secretary (Refineries), MOPNG on Monday inaugurated the first unit of the MRPL’s 90 ton per year capacity Vermicomposting project at Mangalore.

see more..
Tata Motors launches Altroz i-Turbo with iRA

Tata Motors launches Altroz i-Turbo with iRA

25 Jan 2021 | 7:26 PM

Kolkata, Jan 25 (UNI) Tata Motors, India’s leading automotive brand, today announced
the launch of the i-Turbo variant along with iRA-connected car technology for its premium
hatchback, Altroz. iRA comes with 27 connected car features along with natural voice
tech, through which the car understands commands not only in English or Hindi, but
also in Hinglish.

see more..

Provide level playing field to Agri-NBFCs in Budget 2021-22: NAFA

25 Jan 2021 | 7:01 PM

Kolkata, Jan 25 (UNI) Agriculture and allied activities employ more than 50 percent of
the workforce and yet remain largely unorganized and fragmented.

see more..
image